Skip Navigation

Journal of Tropical Pediatrics 1997 43(1):42-46; doi:10.1093/tropej/43.1.42
© 1997 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yaseen, H.
Right arrow Articles by Al-Faraidy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yaseen, H.
Right arrow Articles by Al-Faraidy, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

research-article

Effects of Early Indomethacin Administration on Oxygenation and Surfactant Requirement in Low Birth Weight Infants

Hakam Yaseen, CES, DUN*, Khalid Al Umran, MD*, Hassan Ali, MD**, Majd Rustum, CES**, Maha Darwich, CES** and Abdulatif Al-Faraidy, FACHARZT*

*Division of Neonatology, Department of Pediatrics, King Fahd Hospital of the University P.O. Box 40227, Alkhobar 31952, Saudi Arabia
**Department of Pediatrics, Al Hada Hospital P.O. Box 1347, Taif, Saudi Arabia

A previous study found that early intravenous indomethacin administration prolonged respiratory support in very low birth weight infants. We have, therefore, designed a randomized, double blind controlled study to evaluate the oxygenation, and surfactant requirements in preterm low birth weight infants receiving early indomethacin administration.

Premature neonates who received surfactant therapy and on mechanical ventilation were prospectively randomized to receive either placebo or indomethacin (0.2 mg/kg intravenously at 12 postnatal hours and every 24 h for two more doses). Oxygenation was assessed by FiO2 required and arterial/alveolar oxygen (a/A O2) ratio during the first 48 h of life. The doses of surfactant were compared between the two groups.

Twenty-seven infants (n=14 of early indomethacin and n=13 of placebo group) fulfilled inclusion criteria. At admission to the study, there were no differences in the birth weight, gestational age, sex, Apgar scores, a/A O2 ratio, and FiO2. The control group exhibited a significant improvement in oxygenation (FiO2 requirement and a/A O2 compared with the early indomethacin group at 24 (P=0.026 and 0.02, respectively) and 48 h of life (P=0.037 and 0.026, respectively). The requirement of surfactant was significantly larger in the early indomethacin group (P=0.029).

Early indomethacin administration increases oxygen and surfactant requirement.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
P W Fowlie and P G Davis
Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F464 - 466.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.